Business ❯ Mergers and Acquisitions

Pharmaceutical Industry

Investment Biotechnology Drug Development Competition Perrigo Co Cancer Treatment Rare Disease Drugs Genetic Testing AI in Drug Development Obesity Drugs

AstraZeneca in Reported $400bn Talks With Bristol Myers Squibb

A deal of this size would reshape the global pharma market, prompting scrutiny of AstraZeneca’s UK headquarters and its recent tilt toward the U.S.

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Bristol Myers Squibb Buys Orbital Therapeutics for $1.5 Billion to Push In Vivo CAR‑T Into Autoimmune Care

Biontech, Curevac Agree on $740 Million Covid-19 Vaccine Patent Settlement

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Regeneron to Acquire 23andMe for $256 Million Following Bankruptcy Auction

Chemist Warehouse-Sigma Merger Approved, Creating $8.8 Billion Pharma Giant

Eli Lilly Acquires Morphic for $3.2 Billion

Merck to Acquire EyeBio for Up to $3 Billion

FDA Approves Revolutionary $4.25 Million Gene Therapy for Rare Genetic Disorder

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline

Roche to Acquire Carmot Therapeutics in $2.7 Billion Deal

AbbVie Acquires ImmunoGen for $10.1 Billion, Gaining Access to Promising Ovarian Cancer Drug